Related references
Note: Only part of the references are listed.Likelihood Ratio Test-Based Method for Signal Detection in Drug Classes Using FDA's AERS Database
Lan Huang et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2013)
Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities
Luis G. Valerio et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
Zaina P. Qureshi et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
A structural feature-based computational approach for toxicology predictions
Luis G. Valerio et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Best Practices for QSAR Model Development, Validation, and Exploitation
Alexander Tropsha
MOLECULAR INFORMATICS (2010)
In silico toxicology for the pharmaceutical sciences
Luis G. Valerio
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Preclinical Torsades-de-Pointes screens: Advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk
Gary A. Gintant
PHARMACOLOGY & THERAPEUTICS (2008)
Computer-aided prediction of QT-prolongation
Olga A. Tarasova et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2008)
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel
S Ekins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
